高碳酸血症对健康人受试者心肌血流的影响
该研究纳入10名健康男性,采用前瞻性呼气末靶向控制动脉二氧化碳分压,并用82Rb PET/CT系列显像测量心肌血流量。结果显示心肌血流量随高碳酸血症程度增加而升高,呼气末二氧化碳分压60 mm Hg时较基线增加1.92倍,但腺苷负荷下的心肌血流量仍显著高于最大高碳酸血症刺激时。
要点
- 呼气末二氧化碳分压升至60 mm Hg时,心肌血流量较基线增加1.92倍。
- 腺苷负荷下心肌血流量显著高于最大高碳酸血症刺激时(2.00 vs. 0.86 mL/min/g)。
- 所有呼气末二氧化碳分压目标均维持稳定,标准差小于1.5 mm Hg。
核心结论
- 据作者所知,这是首项用PET评估健康人不同水平高碳酸血症时心肌血流量反应的研究。
- 心肌血流量随高碳酸血症水平升高而增加,呼气末二氧化碳分压60 mm Hg时的心肌血流量为基线的两倍。
研究设计与样本
- 10名健康男性接受系列82Rb PET/CT显像,分别在静息状态和6分钟高碳酸血症平台期进行。
- 高碳酸血症平台期包括基线、呼气末二氧化碳分压50、55、60 mm Hg、60 mm Hg重复及基线重复。
- 心肌血流量采用高碳酸血症开始后3分钟注射的82Rb和带流量依赖提取校正的单组织室模型测量。
- 结果与腺苷负荷试验(140 μg/kg/min)所得结果进行比较。
主要发现
- 基线呼气末二氧化碳分压为38.9 ± 0.8 mm Hg(均值 ± 标准差),范围35-43 mm Hg。
- 所有呼气末二氧化碳分压目标均维持稳定,标准差小于1.5 mm Hg。
- 心率、收缩压、心率血压乘积和呼吸频率随高碳酸血症程度加重而增加。
- 在呼气末二氧化碳分压60 mm Hg时,心肌血流量较基线显著增加至1.92倍(0.86 ± 0.24 vs. 0.45 ± 0.08 mL/min/g;P = 0.002)。
- 腺苷给药后心肌血流量显著高于最大高碳酸血症刺激时(2.00 vs. 0.86 mL/min/g;P < 0.0001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Elevation of the end-tidal partial pressure of CO2 (PETco2) increases cerebral and myocardial blood flow (MBF), suggesting that it may be a suitable alternative to pharmacologic stress or exercise for myocardial perfusion imaging. The purpose of this study was to document the pharmacodynamics of CO2 for MBF using prospective end-tidal targeting to precisely control arterial Pco2 and PET to measure the outcome variable, MBF. Methods: Ten healthy men underwent serial 82Rb PET/CT imaging. Imaging was performed at rest and during 6-min hypercapnic plateaus (baseline; PETco2 at 50, 55, and 60 mm Hg; repeat of PETco2 at 60 mm Hg; and repeat of baseline). MBF was measured using 82Rb injected 3 min after the beginning of hypercapnia and a 1-tissue-compartment model with flow-dependent extraction correction. Results were compared with those obtained during an adenosine stress test (140 μg/kg/min). Results: Baseline PETco2 was 38.9 ± 0.8 (mean ± SD) mm Hg (range, 35-43 mm Hg). All PETco2 targets were sustained, with SDs of less than 1.5 mm Hg. Heart rate, systolic blood pressure, rate × pressure product, and respiratory frequency increased with progressive hypercapnia. MBF increased significantly at each level of hypercapnia to 1.92-fold over baseline (0.86 ± 0.24 vs. 0.45 ± 0.08 mL/min/g; P = 0.002) at a PETco2 of 60 mm Hg. MBF after the administration of adenosine was significantly greater than that with the maximal hypercapnic stimulus (2.00 vs. 0.86 mL/min/g; P < 0.0001). Conclusion: To our knowledge, this study is the first to assess the response of MBF to different levels of hypercapnia in healthy humans with PET. MBF increased with increasing levels of hypercapnia; MBF at a PETco2 of 60 mm Hg was double that at baseline.
引用
- Pelletier-Galarneau M, deKemp RA, Hunter CRRN, et al. Effects of Hypercapnia on Myocardial Blood Flow in Healthy Human Subjects. J Nucl Med. 2017. PMID: 28619736. doi:10.2967/jnumed.117.194308
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。